Mass. General Laws c.176G § 4HH

This is an unofficial version of a Massachusetts General Law. For more information on this topic, please see law about health insurance.

Updates

• Added by St.2021, c.29, § 26, effective July 1, 2021
• Repealed by St.2021, c.29, § 27, effective July 1, 2022

(a)

 For the purposes of this section, “Long-term antibiotic therapy” and “Lyme disease” shall have the meaning ascribed to them in section 12DD of chapter 112.

(b)

An individual or group health maintenance contract shall provide coverage for long-term antibiotic therapy for a patient with Lyme disease when determined to be medically necessary and ordered by a licensed physician after making a thorough evaluation of the patient’s symptoms, diagnostic test results or response to treatment. An experimental drug shall be covered as a long-term antibiotic therapy if it is approved for an indication by the United States Food and Drug Administration; provided, however, that a drug, including an experimental drug, shall be covered for an off-label use in the treatment of Lyme disease if the drug has been approved by the United States Food and Drug Administration.

Last updated:	July 29, 2021